Database query, site capability review, and investigator availability are assessed in the first pass.
How ARI Works
From inquiry to close-out: ARI's six-stage process.
ARI manages the full ophthalmology study lifecycle — from initial sponsor inquiry through feasibility, startup, study conduct, and close-out — with structured milestones and sponsor visibility at every stage.
48-hour inquiry response
7-day preliminary feasibility
2–4 week typical activation
Sponsor operations view
IRB or ethics submission, staff training, system access, and supply verification — all with structured milestones.
Enrollment reporting, query resolution, and proactive issue management throughout study conduct.
Step-by-step
Six stages from first inquiry to study close-out.
Initial inquiry
Day 0: Sponsor submits a feasibility request. ARI acknowledges and begins initial review within 48 hours.
Feasibility assessment
Days 1–7: Patient-access review, site capability confirmation, and investigator availability check inform the preliminary feasibility response.
Budget and contract
Days 7–21: Budget development, transparent pricing, and contract execution proceed in parallel with startup preparation.
Site activation
Days 21–35 typical: IRB or ethics submission, investigator training, system access setup, and supply verification prepare sites for enrollment.
Enrollment and conduct
During study conduct: Protocol-compliant execution, data entry, enrollment reporting, and ongoing sponsor communication.
Close-out
Post-last-patient-visit: Database lock support, document archival, reconciliation, and audit-ready study file delivery.
What sponsors can expect
Speed, visibility, and documentation discipline at every stage.
48-hour inquiry acknowledgement
Every sponsor inquiry receives acknowledgement and initial review within 48 hours of submission.
7-day preliminary assessment
The first feasibility response includes patient-access data, site-capability context, and investigator availability.
2–4 week typical startup window
Structured activation with defined milestones — from IRB submission through enrollment readiness.
Operating discipline
Sponsors evaluate risk as much as speed. ARI's process addresses both.
Protocol compliance
Protocol-compliant study conduct and documentation discipline maintained across all six sites.
IRB and ethics workflow
Regulatory submissions, staff training, and ethics oversight are structured milestones — not assumptions.
Reporting and communication
Regular sponsor updates, enrollment reporting, and proactive issue management throughout study conduct.
Audit-ready close-out
Document archival, reconciliation, and sponsor-ready study file delivery complete every engagement.